A citation-based method for searching scientific literature

Bhramar Mukherjee, John Oliver Delancey, Leon Raskin, Jessica Everett, Joanne Jeter, Colin B Begg, Irene Orlow, Marianne Berwick, Bruce K Armstrong, Anne Kricker, Loraine D Marrett, Robert C Millikan, Hoda Anton Culver, Stefano Rosso, Roberto Zanetti, Peter A Kanetsky, Lynn From, Stephen B Gruber. J Natl Cancer Inst 2012
Times Cited: 32







List of co-cited articles
292 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL.
Alisa M Goldstein, May Chan, Mark Harland, Elizabeth M Gillanders, Nicholas K Hayward, Marie-Francoise Avril, Esther Azizi, Giovanna Bianchi-Scarra, D Timothy Bishop, Brigitte Bressac-de Paillerets,[...]. Cancer Res 2006
279
46

High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families.
Hildur Helgadottir, Veronica Höiom, Göran Jönsson, Rainer Tuominen, Christian Ingvar, Ake Borg, Håkan Olsson, Johan Hansson. J Med Genet 2014
50
43

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008
118
40

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002
337
40

Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents.
Alisa M Goldstein, May Chan, Mark Harland, Nicholas K Hayward, Florence Demenais, D Timothy Bishop, Esther Azizi, Wilma Bergman, Giovanna Bianchi-Scarra, William Bruno,[...]. J Med Genet 2007
259
37

Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.
A M Goldstein, M C Fraser, J P Struewing, C J Hussussian, K Ranade, D P Zametkin, L S Fontaine, S M Organic, N C Dracopoli, W H Clark. N Engl J Med 1995
487
37

High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.
A Borg, T Sandberg, K Nilsson, O Johannsson, M Klinker, A Måsbäck, J Westerdahl, H Olsson, C Ingvar. J Natl Cancer Inst 2000
249
34


A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.
Corine Bertolotto, Fabienne Lesueur, Sandy Giuliano, Thomas Strub, Mahaut de Lichy, Karine Bille, Philippe Dessen, Benoit d'Hayer, Hamida Mohamdi, Audrey Remenieras,[...]. Nature 2011
326
31

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
221
31

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
277
28

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
201
28

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
28

Germline p16 mutations in familial melanoma.
C J Hussussian, J P Struewing, A M Goldstein, P A Higgins, D S Ally, M D Sheahan, W H Clark, M A Tucker, N C Dracopoli. Nat Genet 1994
25

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.
Hanne Eknes Puntervoll, Xiaohong R Yang, Hildegunn Høberg Vetti, Ingeborg M Bachmann, Marie Françoise Avril, Meriem Benfodda, Caterina Catricalà, Stéphane Dalle, Anne B Duval-Modeste, Paola Ghiorzo,[...]. J Med Genet 2013
79
25

Germline mutations in BAP1 predispose to melanocytic tumors.
Thomas Wiesner, Anna C Obenauf, Rajmohan Murali, Isabella Fried, Klaus G Griewank, Peter Ulz, Christian Windpassinger, Werner Wackernagel, Shea Loy, Ingrid Wolf,[...]. Nat Genet 2011
462
25

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
L Zuo, J Weger, Q Yang, A M Goldstein, M A Tucker, G J Walker, N Hayward, N C Dracopoli. Nat Genet 1996
611
25

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.
Miriam Potrony, Joan Anton Puig-Butillé, Paula Aguilera, Celia Badenas, Cristina Carrera, Josep Malvehy, Susana Puig. J Am Acad Dermatol 2014
36
25

Clinical features predicting identification of CDKN2A mutations in Italian patients with familial cutaneous melanoma.
Lucia Pedace, Paola De Simone, Marco Castori, Isabella Sperduti, Vitaliano Silipo, Laura Eibenschutz, Carmelilia De Bernardo, Pierluigi Buccini, Elvira Moscarella, Chiara Panetta,[...]. Cancer Epidemiol 2011
19
36

Clinical and histologic characteristics of malignant melanoma in families with a germline mutation in CDKN2A.
Jasper I van der Rhee, Pieta Krijnen, Nelleke A Gruis, Femke A de Snoo, Hans F A Vasen, Hein Putter, Nicole A Kukutsch, Wilma Bergman. J Am Acad Dermatol 2011
30
23

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history.
P Ghiorzo, L Pastorino, P Queirolo, W Bruno, M G Tibiletti, S Nasti, V Andreotti, B Bressac-de Paillerets, G Bianchi Scarrà. Pigment Cell Melanoma Res 2013
65
21

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
102
21

MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
Maria Concetta Fargnoli, Sara Gandini, Ketty Peris, Patrick Maisonneuve, Sara Raimondi. Eur J Cancer 2010
58
21

Characterization of ligurian melanoma families and risk of occurrence of other neoplasia.
P Ghiorzo, P Ciotti, M Mantelli, A Heouaine, P Queirolo, M L Rainero, C Ferrari, P L Santi, R De Marchi, A Farris,[...]. Int J Cancer 1999
68
18

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.
N Soufir, M F Avril, A Chompret, F Demenais, J Bombled, A Spatz, D Stoppa-Lyonnet, J Bénard, B Bressac-de Paillerets. Hum Mol Genet 1998
308
18

Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families.
Ching-Ni Jenny Njauw, Ivana Kim, Adriano Piris, Michele Gabree, Michael Taylor, Anne Marie Lane, Margaret M DeAngelis, Evangelos Gragoudas, Lyn M Duncan, Hensin Tsao. PLoS One 2012
171
18

BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs.
Michele Carbone, Laura Korb Ferris, Francine Baumann, Andrea Napolitano, Christopher A Lum, Erin G Flores, Giovanni Gaudino, Amy Powers, Peter Bryant-Greenwood, Thomas Krausz,[...]. J Transl Med 2012
190
18

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
Mohamed H Abdel-Rahman, Robert Pilarski, Colleen M Cebulla, James B Massengill, Benjamin N Christopher, Getachew Boru, Peter Hovland, Frederick H Davidorf. J Med Genet 2011
299
18

Genetics of familial melanoma: 20 years after CDKN2A.
Lauren G Aoude, Karin A W Wadt, Antonia L Pritchard, Nicholas K Hayward. Pigment Cell Melanoma Res 2015
82
18

Prospective risk of cancer in CDKN2A germline mutation carriers.
A M Goldstein, J P Struewing, M C Fraser, M W Smith, M A Tucker. J Med Genet 2004
53
15

Germline BAP1 mutations predispose to malignant mesothelioma.
Joseph R Testa, Mitchell Cheung, Jianming Pei, Jennifer E Below, Yinfei Tan, Eleonora Sementino, Nancy J Cox, A Umran Dogan, Harvey I Pass, Sandra Trusa,[...]. Nat Genet 2011
626
15

Germline BAP1 mutations predispose to renal cell carcinomas.
Tatiana Popova, Lucie Hebert, Virginie Jacquemin, Sophie Gad, Virginie Caux-Moncoutier, Catherine Dubois-d'Enghien, Bénédicte Richaudeau, Xavier Renaudin, Jason Sellers, André Nicolas,[...]. Am J Hum Genet 2013
178
15

Hereditary uveal melanoma: a report of a germline mutation in BAP1.
Veronica Höiom, Daniel Edsgärd, Hildur Helgadottir, Hanna Eriksson, Charlotta All-Ericsson, Rainer Tuominen, Ivayla Ivanova, Joakim Lundeberg, Olof Emanuelsson, Johan Hansson. Genes Chromosomes Cancer 2013
39
15

Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing.
Lisa G Aspinwall, Jennifer M Taber, Wendy Kohlmann, Samantha L Leaf, Sancy A Leachman. Genet Med 2014
33
15

Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Richard A Sturm, Carly Fox, Phil McClenahan, Kasturee Jagirdar, Maider Ibarrola-Villava, Parastoo Banan, Nicola C Abbott, Gloria Ribas, Brian Gabrielli, David L Duffy,[...]. J Invest Dermatol 2014
52
15

Germline mutations in shelterin complex genes are associated with familial glioma.
Matthew N Bainbridge, Georgina N Armstrong, M Monica Gramatges, Alison A Bertuch, Shalini N Jhangiani, Harsha Doddapaneni, Lora Lewis, Joseph Tombrello, Spyros Tsavachidis, Yanhong Liu,[...]. J Natl Cancer Inst 2014
133
15

Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22.
L A Cannon-Albright, D E Goldgar, L J Meyer, C M Lewis, D E Anderson, J W Fountain, M E Hegi, R W Wiseman, E M Petty, A E Bale. Science 1992
485
15

Prospective risk of cancer and the influence of tobacco use in carriers of the p16-Leiden germline variant.
Thomas P Potjer, Heidi E Kranenburg, Wilma Bergman, Wouter H de Vos tot Nederveen Cappel, Hester S van Monsjou, Daniela Q C M Barge-Schaapveld, Hans F A Vasen. Eur J Hum Genet 2015
20
25

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
Marcia Irene Canto, Femme Harinck, Ralph H Hruban, George Johan Offerhaus, Jan-Werner Poley, Ihab Kamel, Yung Nio, Richard S Schulick, Claudio Bassi, Irma Kluijt,[...]. Gut 2013
448
15

Melanoma genetics.
Jazlyn Read, Karin A W Wadt, Nicholas K Hayward. J Med Genet 2016
116
15

MC1R variation and melanoma risk in the Swedish population in relation to clinical and pathological parameters.
Veronica Höiom, Rainer Tuominen, Max Käller, Diana Lindén, Afshin Ahmadian, Eva Månsson-Brahme, Suzanne Egyhazi, Klas Sjöberg, Joakim Lundeberg, Johan Hansson. Pigment Cell Melanoma Res 2009
31
12


Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.
A M Goldstein, J P Struewing, A Chidambaram, M C Fraser, M A Tucker. J Natl Cancer Inst 2000
135
12

Novel germline CDKN2A mutation associated with head and neck squamous cell carcinomas and melanomas.
Rubén Cabanillas, Aurora Astudillo, Miguel Valle, Jorge de la Rosa, Rebeca Álvarez, Noelia S Durán, Juan Cadiñanos. Head Neck 2013
15
26

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.
Robert R McWilliams, Eric D Wieben, Kari G Rabe, Katrina S Pedersen, Yanhong Wu, Hugues Sicotte, Gloria M Petersen. Eur J Hum Genet 2011
79
12

Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Johan Hansson, Mia Bergenmar, Per-Ake Hofer, Göran Lundell, Eva Månsson-Brahme, Ulrik Ringborg, Ingrid Synnerstad, Annika Ternesten Bratel, Ann-Marie Wennberg, Inger Rosdahl. J Clin Oncol 2007
30
13

Selection criteria for genetic assessment of patients with familial melanoma.
Sancy A Leachman, John Carucci, Wendy Kohlmann, Kimberly C Banks, Maryam M Asgari, Wilma Bergman, Giovanna Bianchi-Scarrà, Teresa Brentnall, Brigitte Bressac-de Paillerets, William Bruno,[...]. J Am Acad Dermatol 2009
108
12

Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma.
V Nikolaou, X Kang, A Stratigos, H Gogas, M C Latorre, M Gabree, M Plaka, C N Njauw, K Kypreou, I Mirmigi,[...]. Br J Dermatol 2011
28
14

Population-based analysis of prognostic factors and survival in familial melanoma.
Scott R Florell, Kenneth M Boucher, Gilda Garibotti, John Astle, Richard Kerber, Geraldine Mineau, Charles Wiggins, R Dirk Noyes, Alexander Tsodikov, Lisa A Cannon-Albright,[...]. J Clin Oncol 2005
69
12

CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Paola Ghiorzo, Giuseppe Fornarini, Stefania Sciallero, Linda Battistuzzi, Fiorenza Belli, Loris Bernard, Luigina Bonelli, Giacomo Borgonovo, William Bruno, Franco De Cian,[...]. J Med Genet 2012
48
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.